Improving the oral bioavailability of beneficial polyphenols through designed synergies

Genes and Nutrition

Volumn 5, Issue 1, 2010, Pages 75-87

  Scheepens, Arjan ^a   Tan, Kee ^a   Paxton, James W ^b  

^a THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

ABC transporters; Bioavailability; Functional food; Phases 1 and 2 metabolism; Polyphenol; Synergy

Indexed keywords

ABC TRANSPORTER; AMINE OXIDASE (FLAVIN CONTAINING); HYPERICUM PERFORATUM EXTRACT; MONOAMINE OXIDASE INHIBITOR; POLYPHENOL;

BACTERIAL METABOLISM; BLOOD BRAIN BARRIER; CHEESE REACTION; CHEMICAL MODIFICATION; DIETARY INTAKE; DIGESTION; DRUG BIOAVAILABILITY; ENZYME INDUCTION; ENZYME MODIFICATION; ENZYME REGULATION; FOOD COMPOSITION; FOOD DRUG INTERACTION; FUNCTIONAL FOOD; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEALTH PROMOTION; HIGH THROUGHPUT SCREENING; HUMAN; HYPERTENSION; INTESTINE FLORA; METABOLISM; MIGRAINE; NONHUMAN; NUTRIGENOMICS; PHYTOCHEMISTRY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STOMACH ABSORPTION;

ANIMALIA;

EID: 77149154996     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-009-0148-z     Document Type: Review

References (92)

1. MF Andreasen PA Kroon G Williamson MT Garcia-Conesa 2001 Esterase activity able to hydrolyze dietary antioxidant hydroxycinnamates is distributed along the intestine of mammals J Agric Food Chem 49 5679 5684 10.1021/jf010668c 1:CAS:528:DC%2BD3MXnvVOlt7w%3D 11714377 (Pubitemid 33089725)
2. DG Bailey JD Spence C Munoz JM Arnold 1991 Interaction of citrus juices with felodipine and nifedipine Lancet 337 268 269 10.1016/0140-6736(91)90872-M 1:CAS:528:DyaK3MXhslWitLg%3D 1671113
3. GW Barone BJ Gurley BL Ketel ML Lightfoot SR Abul-Ezz 2000 Drug interaction between St. John's wort and cyclosporine Ann Pharmacother 34 1013 1016 10.1345/aph.10088 1:STN:280:DC%2BD3M%2FmsVOltg%3D%3D 10981246
4. J Bouayed H Rammal A Dicko C Younos R Soulimani 2007 Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects J Neurol Sci 262 77 84 10.1016/j.jns.2007.06.028 1:CAS:528:DC%2BD2sXhtVCnsrfF 17698084 (Pubitemid 47398894)
5. W Brand ME Schutte G Williamson JJ van Zanden NH Cnubben JP Groten PJ van Bladeren IM Rietjens 2006 Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients Biomed Pharmacother 60 508 519 10.1016/j.biopha.2006.07.081 1:CAS:528:DC%2BD28XhtFers77L 16978825 (Pubitemid 44635082)
6. V Butterweck H Derendorf 2008 Potential of pharmacokinetic profiling for detecting herbal interactions with drugs Clin Pharmacokinet 47 383 397 10.2165/00003088-200847060-00003 1:CAS:528:DC%2BD1cXos1ehsro%3D 18479173 (Pubitemid 351685388)
7. F Chimenti F Cottiglia L Bonsignore L Casu M Casu C Floris D Secci A Bolasco P Chimenti A Granese O Befani P Turini S Alcaro F Ortuso G Trombetta A Loizzo I Guarino 2006 Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study J Nat Prod 69 945 949 10.1021/np060015w 1:CAS:528:DC%2BD28XkvVehu7w%3D 16792415 (Pubitemid 44166270)
8. JS Choi BC Choi KE Choi 2004 Effect of quercetin on the pharmacokinetics of oral cyclosporine Am J Health Syst Pharm 61 2406 2409 1:CAS:528: DC%2BD2cXhtFWqt7vK 15581264
9. V Crespy C Morand C Besson C Manach C Demigne C Remesy 2002 Quercetin, but not its glycosides, is absorbed from the rat stomach J Agric Food Chem 50 618 621 10.1021/jf010919h 1:CAS:528:DC%2BD3MXptFymsbY%3D 11804539 (Pubitemid 34106688)
10. A Dahan H Altman 2004 Food-drug interaction: grapefruit juice augments drug bioavailability-mechanism, extent and relevance Eur J Clin Nutr 58 1 9 10.1038/sj.ejcn.1601736 1:CAS:528:DC%2BD3sXpvVShu7k%3D 14679360 (Pubitemid 38159306)
11. AJ Day YP Bao MRA Morgan G Williamson 2000 Conjugation position of quercetin glucuronides and effect on biological activity Free Radic Biol Med 29 1234 1243 10.1016/S0891-5849(00)00416-0 1:CAS:528:DC%2BD3cXoslGnsr0%3D 11118813
12. AJ Day F Mellon D Barron G Sarrazin MR Morgan G Williamson 2001 Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin Free Radic Res 35 941 952 10.1080/10715760100301441 1:CAS:528:DC%2BD38XmvVehsg%3D%3D 11811545
13. D Durr B Stieger GA Kullak-Ublick KM Rentsch HC Steinert PJ Meier K Fattinger 2000 St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 Clin Pharmacol Ther 68 598 604 10.1067/mcp.2000.112240 1:CAS:528:DC%2BD3MXht1Sjs7Y%3D 11180019 (Pubitemid 32059985)
14. EA Eaton UK Walle AJ Lewis T Hudson AA Wilson T Walle 1996 Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase: potential role in drug metabolism and chemoprevention Drug Metab Dispos 24 232 237 1:CAS:528:DyaK28XhtFCrs7Y%3D 8742236
15. JD Fernstrom 1990 Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet J Nutr Biochem 1 508 517 10.1016/0955-2863(90)90033-H 1:CAS:528:DyaK3MXhsVWrt7s%3D 15539167 (Pubitemid 20360410)
16. MB Fisher MF Paine TJ Strelevitz SA Wrighton 2001 The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism Drug Metab Rev 33 273 297 10.1081/DMR-120000653 1:CAS:528:DC%2BD38XjvVGqsg%3D%3D 11768770 (Pubitemid 33136266)
17. U Fuhr K Klittich AH Staib 1993 Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man Br J Clin Pharmacol 35 431 436 1:CAS:528:DyaK3sXisVKqtLs%3D 8485024
18. L Gandhi MW Harding M Neubauer CJ Langer M Moore HJ Ross BE Johnson TJ Lynch 2007 A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer Cancer 109 924 932 10.1002/cncr.22492 1:CAS:528:DC%2BD2sXjsVKnsL0%3D 17285598 (Pubitemid 46333534)
19. DM Gardner KI Shulman SE Walker SA Tailor 1996 The making of a user friendly MAOI diet J Clin Psychiatry 57 99 104 1:STN:280:DyaK287ovFCjtQ%3D%3D 8617704
20. EU Graefe J Wittig S Mueller AK Riethling B Uehleke B Drewelow H Pforte G Jacobasch H Derendorf M Veit 2001 Pharmacokinetics and bioavailability of quercetin glycosides in humans J Clin Pharmacol 41 492 499 10.1177/ 00912700122010366 1:CAS:528:DC%2BD3MXjvVaksb0%3D 11361045 (Pubitemid 32381866)
21. DJ Greenblatt LL von Moltke JS Harmatz G Chen JL Weemhoff C Jen CJ Kelley BW LeDuc MA Zinny 2003 Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice Clin Pharmacol Ther 74 121 129 10.1016/S0009-9236(03)00118-8 1:CAS:528:DC%2BD3sXlvVCrt70%3D 12891222 (Pubitemid 36951809)
22. AL Halberstadt MR Buell VL Masten VB Risbrough MA Geyer 2008 Modification of the effects of 5-methoxy-N, N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors Psychopharmacology (Berl) 201 55 66 10.1007/s00213-008-1247-z 1:CAS:528:DC%2BD1cXht1GrurbN
23. XH Han SS Hong JS Hwang MK Lee BY Hwang JS Ro 2007 Monoamine oxidase inhibitory components from Cayratia japonica Arch Pharm Res 30 13 17 10.1007/BF02977772 1:CAS:528:DC%2BD2sXhvVKlu7o%3D 17328236
24. JE Hardebo C Owman 1980 Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface Ann Neurol 8 1 31 10.1002/ana.410080102 1:CAS:528:DyaL3cXlt12itb4%3D 6105837 (Pubitemid 10056344)
25. RM Harris DM Wood L Bottomley S Blagg K Owen PJ Hughes RH Waring CJ Kirk 2004 Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment J Clin Endocrinol Metab 89 1779 1787 10.1210/jc.2003-031631 1:CAS:528:DC%2BD2cXjt1elt74%3D 15070945 (Pubitemid 38507934)
26. M Hennessy D Kelleher JP Spiers M Barry P Kavanagh D Back F Mulcahy J Feely 2002 St Johns wort increases expression of P-glycoprotein: implications for drug interactions Br J Clin Pharmacol 53 75 82 10.1046/j.0306-5251.2001. 01516.x 1:CAS:528:DC%2BD38XhtFWrs7k%3D 11849198 (Pubitemid 34117742)
27. S Hoffmeyer O Burk O von Richter HP Arnold J Brockmoller A Johne I Cascorbi T Gerloff I Roots M Eichelbaum U Brinkmann 2000 Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Proc Natl Acad Sci USA 97 3473 3478 10.1073/pnas.050585397 1:CAS:528:DC%2BD3cXitlWqtL8%3D 10716719 (Pubitemid 30183327)
28. J Hong JD Lambert SH Lee PJ Sinko CS Yang 2003 Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites Biochem Biophys Res Commun 310 222 227 10.1016/j.bbrc.2003.09.007 1:CAS:528:DC%2BD3sXnsVWktrY%3D 14511674 (Pubitemid 37162786)
29. M Hu J Chen H Lin 2003 Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model J Pharmacol Exp Ther 307 314 321 10.1124/jpet.103.053496 1:CAS:528: DC%2BD3sXnslGku7k%3D 12893842 (Pubitemid 37151923)
30. M Ingelman-Sundberg SC Sim A Gomez C Rodriguez-Antona 2007 Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects Pharmacol Ther 116 496 526 10.1016/j.pharmthera.2007.09.004 1:CAS:528:DC%2BD2sXhtlCrs7bE 18001838 (Pubitemid 350116943)
31. KM Janisch G Williamson P Needs GW Plumb 2004 Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin Free Radic Res 38 877 884 10.1080/10715760410001728415 1:CAS:528:DC%2BD2cXmtFWgsrc%3D 15493462 (Pubitemid 39077375)
32. DO Kennedy S Pace C Haskell EJ Okello A Milne AB Scholey 2006 Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery Neuropsychopharmacology 31 845 852 10.1038/sj.npp.1300907 1:CAS:528:DC%2BD28XitlKmsbo%3D 16205785
33. SP Khor A Hsu 2007 The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease Curr Clin Pharmacol 2 234 243 10.2174/157488407781668802 1:CAS:528:DC%2BD2sXhtVWgurrE 18690870 (Pubitemid 47520962)
34. RB Kim BF Leake EF Choo GK Dresser SV Kubba UI Schwarz A Taylor HG Xie J McKinsey S Zhou LB Lan JD Schuetz EG Schuetz GR Wilkinson 2001 Identification of functionally variant MDR1 alleles among European Americans and African Americans Clin Pharmacol Ther 70 189 199 10.1067/mcp.2001.117412 1:CAS:528:DC%2BD3MXmslygs7o%3D 11503014 (Pubitemid 32777772)
35. JD Lambert SM Sang CS Yang 2007 Biotransformation of green tea polyphenols and the biological activities of those metabolites Mol Pharmaceutics 4 819 825 10.1021/mp700075m 1:CAS:528:DC%2BD2sXht1altr%2FK
36. DF Lewis Y Ito 2008 Human cytochromes P450 in the metabolism of drugs: new molecular models of enzyme-substrate interactions Expert Opin Drug Metab Toxicol 4 1181 1186 10.1517/17425255.4.9.1181 1:CAS:528:DC%2BD1cXhtVaisLzE 18721112
37. KS Lown JC Kolars KE Thummel JL Barnett KL Kunze SA Wrighton PB Watkins 1994 Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: lack of prediction by the erythromycin breath test Drug Metab Dispos 22 947 955 1:CAS:528:DyaK2MXisFCmtLk%3D 7895614
38. WA Maish EM Hampton TL Whitsett JD Shepard WR Lovallo 1996 Influence of grapefruit juice on caffeine pharmacokinetics and pharmacodynamics Pharmacotherapy 16 1046 1052 1:CAS:528:DyaK2sXitFaks74%3D 8947977
39. ML Maitland A DiRienzo MJ Ratain 2006 Interpreting disparate responses to cancer therapy: the role of human population genetics J Clin Oncol 24 2151 2157 10.1200/JCO.2005.05.2282 16682733 (Pubitemid 46630687)
40. C Manach A Scalbert C Morand C Remesy L Jimenez 2004 Polyphenols: food sources and bioavailability Am J Clin Nutr 79 727 747 1:CAS:528: DC%2BD2cXjs1ygsL4%3D 15113710
41. C Manach G Williamson C Morand A Scalbert C Remesy 2005 Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am J Clin Nutr 81 230S 242S 1:CAS:528:DC%2BD2MXlvFKltA%3D%3D 15640486
42. JS Markowitz JL Donovan CL DeVane RM Taylor Y Ruan JS Wang KD Chavin 2003 Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme JAMA 290 1500 1504 10.1001/jama.290.11.1500 1:CAS:528: DC%2BD3sXntlCmsbg%3D 13129991 (Pubitemid 37430406)
43. CR Markus B Olivier GE Panhuysen J Van Der Gugten MS Alles A Tuiten HG Westenberg D Fekkes HF Koppeschaar EE de Haan 2000 The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress Am J Clin Nutr 71 1536 1544 1:CAS:528:DC%2BD3cXjvFGns7o%3D 10837296
44. R Markus G Panhuysen A Tuiten H Koppeschaar 2000 Effects of food on cortisol and mood in vulnerable subjects under controllable and uncontrollable stress Physiol Behav 70 333 342 10.1016/S0031-9384(00)00265-1 1:CAS:528:DC%2BD3cXmslOju7g%3D 11006432
45. DJ McKenna GH Towers F Abbott 1984 Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca J Ethnopharmacol 10 195 223 10.1016/0378-8741(84)90003-5 1:CAS:528:DyaL2cXks1Sjsb8%3D 6587171 (Pubitemid 14081500)
46. J Molnar N Gyemant M Tanaka J Hohmann E Bergmann-Leitner P Molnar J Deli R Didiziapetris MJ Ferreira 2006 Inhibition of multidrug resistance of cancer cells by natural diterpenes, triterpenes and carotenoids Curr Pharm Des 12 287 311 10.2174/138161206775201893 1:CAS:528:DC%2BD28XitlCruw%3D%3D 16454745
47. M Monteiro A Farah D Perrone LC Trugo C Donangelo 2007 Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans J Nutr 137 2196 2201 1:CAS:528:DC%2BD2sXhtFeksbrP 17884997
48. YJ Moon ME Morris 2007 Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats Mol Pharm 4 865 872 10.1021/mp7000928 1:CAS:528: DC%2BD2sXht1egsLbE 17970592
49. YJ Moon X Wang ME Morris 2006 Dietary flavonoids: effects on xenobiotic and carcinogen metabolism Toxicol In Vitro 20 187 210 10.1016/j.tiv.2005.06.048 1:CAS:528:DC%2BD28XksVensQ%3D%3D 16289744 (Pubitemid 43087702)
50. LB Moore B Goodwin SA Jones GB Wisely CJ Serabjit-Singh TM Willson JL Collins SA Kliewer 2000 St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc Natl Acad Sci USA 97 7500 7502 10.1073/pnas.130155097 1:CAS:528:DC%2BD3cXksVKhs7s%3D 10852961 (Pubitemid 30431492)
51. ME Morris S Zhang 2006 Flavonoid-drug interactions: effects of flavonoids on ABC transporters Life Sci 78 2116 2130 10.1016/j.lfs.2005.12.003 1:CAS:528:DC%2BD28XisF2qsb0%3D 16455109
52. PK Mukherjee V Kumar M Mal PJ Houghton 2007 Acetylcholinesterase inhibitors from plants Phytomedicine 14 289 300 10.1016/j.phymed.2007.02.002 1:CAS:528:DC%2BD2sXmtFKmsbk%3D 17346955 (Pubitemid 46415622)
53. T Murakami M Takano 2008 Intestinal efflux transporters and drug absorption Expert Opin Drug Metab Toxicol 4 923 939 10.1517/17425255.4.7.923 1:CAS:528:DC%2BD1cXos1Chur4%3D 18624680
54. RS Obach 2000 Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression J Pharmacol Exp Ther 294 88 95 1:CAS:528:DC%2BD3cXksFyht7s%3D 10871299
55. D Pal AK Mitra 2006 MDR- and CYP3A4-mediated drug-drug interactions J Neuroimmune Pharmacol 1 323 339 10.1007/s11481-006-9034-2 18040809 (Pubitemid 44244137)
56. J Patel B Buddha S Dey D Pal AK Mitra 2004 In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity Am J Ther 11 262 277 10.1097/01.mjt.0000101827.94820.22 15266218
57. WX Peng HD Li HH Zhou 2003 Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers Eur J Clin Pharmacol 59 237 241 10.1007/s00228-003-0596-0 1:CAS:528:DC%2BD3sXlslGrtL0%3D 12756512 (Pubitemid 37006395)
58. MD Perloff LL von Moltke E Stormer RI Shader DJ Greenblatt 2001 Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure Br J Pharmacol 134 1601 1608 10.1038/sj.bjp.0704399 1:CAS:528:DC%2BD38XkvVei 11739235
59. SC Piscitelli AH Burstein D Chaitt RM Alfaro J Falloon 2000 Indinavir concentrations and St John's wort Lancet 355 547 548 10.1016/S0140-6736(99) 05712-8 1:CAS:528:DC%2BD3cXhs1elsbs%3D 10683007
60. SC Piscitelli AH Burstein N Welden KD Gallicano J Falloon 2002 The effect of garlic supplements on the pharmacokinetics of saquinavir Clin Infect Dis 34 234 238 10.1086/324351 11740713 (Pubitemid 34028358)
61. L Quintieri P Palatini A Nassi P Ruzza M Floreani 2008 Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes Biochem Pharmacol 75 1426 1437 10.1016/j.bcp.2007.11.012 1:CAS:528:DC%2BD1cXislamtbY%3D 18191104
62. J Radtke J Linseisen G Wolfram 1998 Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey Z Ernahrungswiss 37 190 197 10.1007/s003940050016 1:CAS:528:DyaK1cXktlKiur8%3D 9698647 (Pubitemid 28318362)
63. I Rodeiro MT Donato A Lahoz G Garrido R Delgado MJ Gomez-Lechon 2008 Interactions of polyphenols with the P450 system: possible implications on human therapeutics Mini Rev Med Chem 8 97 106 10.2174/138955708783498131 1:CAS:528:DC%2BD1cXitVSltbs%3D 18289092 (Pubitemid 351320934)
64. P Rojas C Rojas M Ebadi S Montes A Monroy-Noyola N Serrano-Garcia 2004 EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity Neurochem Res 29 1417 1423 10.1023/B:NERE.0000026406.64547.93 1:CAS:528:DC%2BD2cXjs1KisLw%3D 15202774 (Pubitemid 39011329)
65. F Ruschitzka PJ Meier M Turina TF Luscher G Noll 2000 Acute heart transplant rejection due to Saint John's wort Lancet 355 548 549 10.1016/S0140-6736(99)05467-7 1:STN:280:DC%2BD3c7ksFaisQ%3D%3D 10683008
66. JB Salgueiro P Ardenghi M Dias MB Ferreira I Izquierdo JH Medina 1997 Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats Pharmacol Biochem Behav 58 887 891 10.1016/S0091-3057(97)00054-3 1:CAS:528:DyaK2sXnvFems7s%3D 9408191 (Pubitemid 28108193)
67. T Sousa R Paterson V Moore A Carlsson B Abrahamsson AW Basit 2008 The gastrointestinal microbiota as a site for the biotransformation of drugs Int J Pharm 363 1 25 10.1016/j.ijpharm.2008.07.009 1:CAS:528:DC%2BD1cXhtFegu7jI 18682282
68. C Sridar TC Goosen UM Kent JA Williams PF Hollenberg 2004 Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases Drug Metab Dispos 32 587 594 10.1124/dmd.32.6.587 1:CAS:528:DC%2BD2cXktlOgtrw%3D 15155549 (Pubitemid 38668150)
69. GE Stein MJ Gurwith 1984 Amoxicillin potassium clavulanate, a beta-lactamase-resistant antibiotic combination Clin Pharm 3 591 599 1:CAS:528:DyaL2MXjvFeksg%3D%3D 6391783
70. DE Stevenson JM Cooney DJ Jensen R Wibisono A Adaim MA Skinner J Zhang 2008 Comparison of enzymically glucuronidated flavonoids with flavonoid aglycones in an in vitro cellular model of oxidative stress protection In Vitro Cell Dev Biol Anim 44 73 80 10.1007/s11626-007-9072-y 1:CAS:528: DC%2BD1cXmtFKqs7k%3D 18219540
71. DE Stevenson RD Hurst 2007 Polyphenolic phytochemicals-just antioxidants or much more? Cell Mol Life Sci 64 2900 2916 10.1007/s00018-007-7237-1 1:CAS:528:DC%2BD2sXhsVals7jF 17726576 (Pubitemid 351152245)
72. S Suri MA Taylor A Verity S Tribolo PW Needs PA Kroon DA Hughes VG Wilson 2008 A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro Biochem Pharmacol 76 645 653 10.1016/j.bcp.2008.06.010 1:CAS:528:DC%2BD1cXhtVSitbfL 18639531
73. NT Tildesley DO Kennedy EK Perry CG Ballard S Savelev KA Wesnes AB Scholey 2003 Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers Pharmacol Biochem Behav 75 669 674 10.1016/S0091-3057(03)00122- 9 1:CAS:528:DC%2BD3sXlvVWhtr8%3D 12895685 (Pubitemid 36936901)
74. BL Urquhart RG Tirona RB Kim 2007 Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs J Clin Pharmacol 47 566 578 10.1177/0091270007299930 1:CAS:528:DC%2BD2sXlsVKkt7Y%3D 17442683 (Pubitemid 46632158)
75. JB Vaidyanathan T Walle 2003 Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2 J Pharmacol Exp Ther 307 745 752 10.1124/jpet.103.054296 1:CAS:528: DC%2BD3sXos1ShsLw%3D 12970388 (Pubitemid 37310692)
76. K van de Wetering A Burkon W Feddema A Bot H de Jonge V Somoza P Borst 2008 Intestinal BCRP/Bcrp1 and MRP3/Mrp3 are involved in the pharmacokinetics of resveratrol Mol Pharmacol 75 4 876 885 10.1124/mol.108.052019 19114588
77. VJ Wacher JA Silverman Y Zhang LZ Benet 1998 Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics J Pharm Sci 87 1322 1330 10.1021/js980082d 1:CAS:528:DyaK1cXltlyhsb0%3D 9811484 (Pubitemid 28514135)
78. T Walle AM Browning LL Steed SG Reed UK Walle 2005 Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans J Nutr 135 48 52 1:CAS:528:DC%2BD2MXltlyktQ%3D%3D 15623831
79. JA Williams R Hyland BC Jones DA Smith S Hurst TC Goosen V Peterkin JR Koup SE Ball 2004 Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios Drug Metab Dispos 32 1201 1208 10.1124/dmd.104.000794 1:CAS:528:DC%2BD2cXovFCktLg%3D 15304429 (Pubitemid 39410902)
80. JA Williams BJ Ring VE Cantrell K Campanale DR Jones SD Hall SA Wrighton 2002 Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes Drug Metab Dispos 30 1266 1273 10.1124/dmd.30.11.1266 1:CAS:528:DC%2BD38XotFyku7g%3D 12386134 (Pubitemid 35265835)
81. EL Woodahl RJ Ho 2004 The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function Curr Drug Metab 5 11 19 10.2174/1389200043489108 1:CAS:528:DC%2BD2cXhvVCisL0%3D 14965248 (Pubitemid 38279406)
82. CC Wu LY Sheen HW Chen WW Kuo SJ Tsai CK Lii 2002 Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats J Agric Food Chem 50 378 383 10.1021/jf010937z 1:CAS:528:DC%2BD3MXptFKjsr4%3D 11782211 (Pubitemid 34052787)
83. J Xing X Chen D Zhong 2005 Absorption and enterohepatic circulation of baicalin in rats Life Sci 78 140 146 10.1016/j.lfs.2005.04.072 1:CAS:528:DC%2BD2MXhtFKmsLrO 16107266 (Pubitemid 41560966)
84. CS Yang JD Lambert J Ju G Lu S Sang 2007 Tea and cancer prevention: molecular mechanisms and human relevance Toxicol Appl Pharmacol 224 265 273 10.1016/j.taap.2006.11.024 1:CAS:528:DC%2BD2sXhtF2mtL7J 17234229 (Pubitemid 47592860)
85. KA Youdim MS Dobbie G Kuhnle AR Proteggente NJ Abbott C Rice-Evans 2003 Interaction between flavonoids and the blood-brain barrier: in vitro studies J Neurochem 85 180 192 1:CAS:528:DC%2BD3sXislOluro%3D 12641740
86. KA Youdim MZ Qaiser DJ Begley CA Rice-Evans NJ Abbott 2004 Flavonoid permeability across an in situ model of the blood-brain barrier Free Radic Biol Med 36 592 604 10.1016/j.freeradbiomed.2003.11.023 1:CAS:528: DC%2BD2cXhsFWktb8%3D 14980703 (Pubitemid 38230176)
87. MB Youdim D Edmondson KF Tipton 2006 The therapeutic potential of monoamine oxidase inhibitors Nat Rev Neurosci 7 295 309 10.1038/nrn1883 1:CAS:528:DC%2BD28Xis1Gksrs%3D 16552415
88. S Zevin NL Benowitz 1999 Drug interactions with tobacco smoking: an update Clin Pharmacokinet 36 425 438 10.2165/00003088-199936060-00004 1:CAS:528:DyaK1MXkvFeju7k%3D 10427467 (Pubitemid 29317490)
89. L Zhang Z Zuo G Lin 2007 Intestinal and hepatic glucuronidation of flavonoids Mol Pharm 4 833 845 10.1021/mp700077z 1:CAS:528:DC%2BD2sXht1Gmt7zF 17979245
90. YC Zhang LZ Benet 2001 The gut as a barrier to drug absorption-combined role of cytochrome P450 3A and P-glycoprotein Clin Pharmacokinet 40 159 168 10.2165/00003088-200140030-00002 1:CAS:528:DC%2BD3MXjsVWmtrs%3D 11327196
91. S Zhou Y Gao W Jiang M Huang A Xu JW Paxton 2003 Interactions of herbs with cytochrome P450 Drug Metab Rev 35 35 98 10.1081/DMR-120018248 1:CAS:528:DC%2BD3sXit1Gqur0%3D 12635815 (Pubitemid 36249785)
92. S Zhou LY Lim B Chowbay 2004 Herbal modulation of P-glycoprotein Drug Metab Rev 36 57 104 10.1081/DMR-120028427 1:CAS:528:DC%2BD2cXhsl2nsbs%3D 15072439 (Pubitemid 38387835)